Mesenchymal Células madre may be a viable tratamiento option for Post Treatment Lyme Disease Syndrome (PTLDS). Células madre have been proven to have strong anti-inflammatory properties. Through the use of large cell quantity transplants, the youthful Células madre have a regulatory nature on the body


organización de contratos de investigación

terapia con células madre